Alina Arulsamy
Bandar, 47500, Malaysia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
GABAA Receptors and Drug-Resistant Epilepsy: Why It's Time to Think Outside the Pore.
Journal: Cellular and molecular neurobiology
Published: February 13, 2026
Acute and subacute oral toxicity assessment of Karanjin in Sprague Dawley rats.
Journal: Toxicology reports
Published: November 07, 2025
Rodent models of genetic epilepsy and its association with neurocognitive impairment- a systematic review.
Journal: Frontiers in pharmacology
Published: July 04, 2025
Exploring metabolic biomarkers and pathways in pharmacoresistant epilepsy: A systematic review.
Journal: Epilepsy research
Published: May 22, 2025
A qualitative study exploring physician perspectives on a cardiac-based seizure prediction digital service for epilepsy management.
Journal: Epilepsy & behavior : E&B
Published: April 29, 2025
Nanoformulations in epilepsy therapy - a systematic review of emerging strategies in status epilepticus.
Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
Published: January 22, 2025
In Silico exploration of Karanjin for anti-obesity potential through ADMET profiling, network pharmacology, molecular docking, and molecular dynamics simulations.
Journal: Scientific reports
Published: November 18, 2024
α7-Nicotinic Acetylcholine Receptor Activation Modulates BV2 Microglial Plasticity via miR-21/TNF-α/NFκB in Oxygen-Glucose Deprivation/Reoxygenation.
Journal: Journal of molecular neuroscience : MN
Published: October 08, 2024
The therapeutic effects of Lacticaseibacillus rhamnosus on stress-induced anxiety: a systematic review of evidence from animal studies.
Journal: Gut microbiome (Cambridge, England)
Published: September 09, 2024
Traumatic brain injury-induced peripheral damage: The dynamics of the inflammatory and autophagy pathway from acute to chronic stages.
Journal: Folia neuropathologica
Published: August 21, 2024
The Role of HMGB1 in Infection-Related Cognitive Deficits.
Journal: Frontiers in bioscience (Landmark edition)
Published: July 04, 2024
High Mobility Group Box-1 (HMGB1), a Key Mediator of Cognitive Decline in Neurotrauma with a Potential for Targeted Therapy: A Comprehensive Review.
Journal: Frontiers in bioscience (Landmark edition)
Published: May 15, 2024
Last Updated: 09/26/2026